145 related articles for article (PubMed ID: 18922918)
1. Balancing between antitumor efficacy and autoimmune pathology in T-cell-mediated targeting of carcinoembryonic antigen.
Bos R; van Duikeren S; Morreau H; Franken K; Schumacher TN; Haanen JB; van der Burg SH; Melief CJ; Offringa R
Cancer Res; 2008 Oct; 68(20):8446-55. PubMed ID: 18922918
[TBL] [Abstract][Full Text] [Related]
2. Vaccine therapy of established tumors in the absence of autoimmunity.
Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
[TBL] [Abstract][Full Text] [Related]
3. Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses.
Kudo-Saito C; Schlom J; Hodge JW
Clin Cancer Res; 2005 Mar; 11(6):2416-26. PubMed ID: 15788693
[TBL] [Abstract][Full Text] [Related]
4. Vaccine-based therapy directed against carcinoembryonic antigen demonstrates antitumor activity on spontaneous intestinal tumors in the absence of autoimmunity.
Greiner JW; Zeytin H; Anver MR; Schlom J
Cancer Res; 2002 Dec; 62(23):6944-51. PubMed ID: 12460911
[TBL] [Abstract][Full Text] [Related]
5. Expression of a natural tumor antigen by thymic epithelial cells impairs the tumor-protective CD4+ T-cell repertoire.
Bos R; van Duikeren S; van Hall T; Kaaijk P; Taubert R; Kyewski B; Klein L; Melief CJ; Offringa R
Cancer Res; 2005 Jul; 65(14):6443-9. PubMed ID: 16024649
[TBL] [Abstract][Full Text] [Related]
6. T cells that target carcinoembryonic antigen eradicate orthotopic pancreatic carcinomas without inducing autoimmune colitis in mice.
Chmielewski M; Hahn O; Rappl G; Nowak M; Schmidt-Wolf IH; Hombach AA; Abken H
Gastroenterology; 2012 Oct; 143(4):1095-107.e2. PubMed ID: 22750462
[TBL] [Abstract][Full Text] [Related]
7. Induction of mucosal and systemic immune responses against human carcinoembryonic antigen by an oral vaccine.
Huang Y; Fayad R; Smock A; Ullrich AM; Qiao L
Cancer Res; 2005 Aug; 65(15):6990-9. PubMed ID: 16061685
[TBL] [Abstract][Full Text] [Related]
8. Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy.
Clarke P; Mann J; Simpson JF; Rickard-Dickson K; Primus FJ
Cancer Res; 1998 Apr; 58(7):1469-77. PubMed ID: 9537250
[TBL] [Abstract][Full Text] [Related]
9. Different forms of helper tolerance to carcinoembryonic antigen: ignorance and regulation.
Pickford WJ; Watson AJ; Barker RN
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4528-37. PubMed ID: 17671139
[TBL] [Abstract][Full Text] [Related]
10. A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses.
Conforti A; Peruzzi D; Giannetti P; Biondo A; Ciliberto G; La Monica N; Aurisicchio L
J Immunother; 2009 Sep; 32(7):744-54. PubMed ID: 19561534
[TBL] [Abstract][Full Text] [Related]
11. CD4+CD25+ regulatory T-cell-inactivation in combination with adenovirus vaccines enhances T-cell responses and protects mice from tumor challenge.
Elia L; Aurisicchio L; Facciabene A; Giannetti P; Ciliberto G; La Monica N; Palombo F
Cancer Gene Ther; 2007 Feb; 14(2):201-10. PubMed ID: 17053815
[TBL] [Abstract][Full Text] [Related]
12. Liver sinusoidal endothelial cells contribute to CD8 T cell tolerance toward circulating carcinoembryonic antigen in mice.
Höchst B; Schildberg FA; Böttcher J; Metzger C; Huss S; Türler A; Overhaus M; Knoblich A; Schneider B; Pantelis D; Kurts C; Kalff JC; Knolle P; Diehl L
Hepatology; 2012 Nov; 56(5):1924-33. PubMed ID: 22610745
[TBL] [Abstract][Full Text] [Related]
13. Signal sequence deletion and fusion to tetanus toxoid epitope augment antitumor immune responses to a human carcinoembryonic antigen (CEA) plasmid DNA vaccine in a murine test system.
Lund LH; Andersson K; Zuber B; Karlsson A; Engström G; Hinkula J; Wahren B; Winberg G
Cancer Gene Ther; 2003 May; 10(5):365-76. PubMed ID: 12719706
[TBL] [Abstract][Full Text] [Related]
14. Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors.
Wilkinson RW; Ross EL; Poulsom R; Ilyas M; Straub J; Snary D; Bodmer WF; Mather SJ
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10256-60. PubMed ID: 11517330
[TBL] [Abstract][Full Text] [Related]
15. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.
Bråve A; Hallengärd D; Gudmundsdotter L; Stout R; Walters R; Wahren B; Hallermalm K
Vaccine; 2009 Jun; 27(28):3692-6. PubMed ID: 19428161
[TBL] [Abstract][Full Text] [Related]
16. Potent control of tumor growth by CEA/CD3-bispecific single-chain antibody constructs that are not competitively inhibited by soluble CEA.
Lutterbuese R; Raum T; Kischel R; Lutterbuese P; Schlereth B; Schaller E; Mangold S; Rau D; Meier P; Kiener PA; Mulgrew K; Oberst MD; Hammond SA; Baeuerle PA; Kufer P
J Immunother; 2009 May; 32(4):341-52. PubMed ID: 19342971
[TBL] [Abstract][Full Text] [Related]
17. Responses of mice immunized with a DNA vaccine encoding carcinoembryonic antigen (CEA).
Johansson S; Engström G; Winberg G; Hinkula J; Wahren B
Vaccine; 2006 May; 24(21):4572-5. PubMed ID: 16159686
[TBL] [Abstract][Full Text] [Related]
18. Individual mouse analysis of the cellular immune response to tumor antigens in peripheral blood by intracellular staining for cytokines.
Giannetti P; Facciabene A; La Monica N; Aurisicchio L
J Immunol Methods; 2006 Oct; 316(1-2):84-96. PubMed ID: 17010367
[TBL] [Abstract][Full Text] [Related]
19. CEA-based vaccines.
Huang EH; Kaufman HL
Expert Rev Vaccines; 2002 Jun; 1(1):49-63. PubMed ID: 12908512
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen as a target for specific antitumor immunotherapy of head and neck cancer.
Kass ES; Greiner JW; Kantor JA; Tsang KY; Guadagni F; Chen Z; Clark B; De Pascalis R; Schlom J; Van Waes C
Cancer Res; 2002 Sep; 62(17):5049-57. PubMed ID: 12208760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
